Screening and detection of ovarian cancer

Journal of Midwifery and Women's Health

Volumn 50, Issue 1, 2005, Pages 51-54

  Breedlove, Ginger ^a   Busenhart, Cara ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF NURSING   (United States)

^b NONE

Author keywords

Diagnosis; Ovarian cancer; Ovarian neoplasm; Proteomics; Screening

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; GEMCITABINE; PACLITAXEL;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD LEVEL; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CANCER STAGING; CASE REPORT; CAUSE OF DEATH; COMMERCIAL PHENOMENA; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FOOD AND DRUG ADMINISTRATION; GYNECOLOGIC CANCER; HEALTH CARE COST; HUMAN; MARKETING; OVARY CANCER; PREDICTION; PRIORITY JOURNAL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVAL TIME; SYMPTOMATOLOGY; TRANSVAGINAL ECHOGRAPHY;

CA-125 ANTIGEN; FEMALE; HUMANS; MASS SCREENING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEOMICS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WOMEN'S HEALTH;

EID: 12144272554     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmwh.2004.10.002     Document Type: Article

References (16)

1. E.M. Posadas B. Davidson E.C. Kohn Proteomics and ovarian cancer: Implications for diagnosis and treatment: A critical review of the literature Curr Opin Oncol 16 2004 478-484
2. American Cancer Society. All about ovarian cancer. [cited September 22, 2004]. Available from: Http://www.cancer.org
3. F. Modugno G.B. Mills C. Simone D.A. Fishman E.C. Kohn L.A. Liotta et al. Ovarian cancer and high-risk women - Implications for prevention, screening, and early detection Gynecol Oncol 91 2003 15-31
4. E.F. Petricoin A.M. Ardekani B.A. Hitt P.J. Levine V.A. Fusaro S.M. Steinberg et al. Use of proteomic patterns in serum to identify ovarian cancer Lancet 359 2002 572-577
5. J.L. Benedet H. Bender H. Jones III H.Y. Ngan S. Pecorelli FIGO Committee on Gynecologic Oncology FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers Int J Gynaecol Obstet 70 2000 209-312
6. T.P. Conrads V.A. Fusaro S. Ross D. Johann V. Rajapakse B.A. Hitt et al. High-resolution serum proteomic features for ovarian cancer detection Endocr Relat Cancer 11 2004 163-178
7. A. Pollack New test for ovarian cancer stirs hope and concern 2004 The New York Times February 5
8. Correlogic Systems, Inc News release: Correlogic Systems' ovarian cancer blood test to advance through North-Shore-LIJ Research Institute research collaboration 2004 June 21
9. Gutman S. Letter to Peter Levine, President and CEO Correlogic Systems, Inc. (July 12, 2004). [cited September 29, 2004]. Available from: http://www.fda.gov/cdrh/oivd/letters/071204-correlogic.html
10. Levine P. Letter to Steven Gutman, Director Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health. [cited September 29, 2004]. Available from: http://www.correlogic.comJuly14SteveGutmanLetter.pdf
11. E. Check Running before we can walk? Nature 429 2004 496-497
12. Society of Gynecologic Oncologists. Society of Gynecologic Oncologists Statement Regarding OvaCheck, February 7, 2004. Available from: http://www.sgo.org/policy/position_Statement.cfm
13. L. Wagner A test before its time? FDA stalls distribution process of proteomic test J Natl Cancer Inst 96 2004 500-501
14. Sorace JM, Zhan M. A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformatics, 4(24). [cited September 21, 2004]. Available from: Www.biomedcentral.com/1471-2105/4/24
15. U.S. Preventive Services Task Force. Screening for ovarian cancer: Brief evidence update. Posted May 2004. Agency for Healthcare Research and Quality, Rockville, MD. [cited October 5, 2004]. Available from: http://www.ahrq.gov/clinic/3rduspstf/ovariancan/ovcanup.htm
16. National Cancer Institute (NCI) News Center. Questions and Answers: Proteomics and cancer. Posted April 30, 2004. [cited October 1, 2004]. Available from: http://www.cancer.gov/newscenter/pressreleases/proteomicsQandA